Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: PRINCETON BIOMEDITECH CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-30 to 2023-09-29
Current total value of award: $10062372.12
Description: RADX TECH II PROJECTS 13356 & 13464: RAPID, POINT OF CARE, MULTIPLEX COVID-19 AND FLU A&B ANTIGEN ASSAY AND READER